|CrossRef Text and Data Mining|
|Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.|
|Antithyroid Drug Treatment in Graves’ Disease|
|Jae Hoon Chung|
Endocrinol Metab. 2021;36(3):491-499. Published online June 16, 2021
Long-Term Antithyroid Drug Treatment of Patients With Graves’ Disease
A Validated Tool Can Predict Risk or Nonrisk of Graves’ Orbitopathy During Antithyroid Drug Treatment of Hyperthyroid Graves’ Disease
Predicting the Risk of Graves Disease Relapse: Commentary on “Thyroid Peroxidase Antibody Positivity is Associated with Relapse-Free Survival Following Antithyroid Drug Treatment for Graves Disease”
Valuable predictive features of relapse of Graves’ disease after antithyroid drug treatment
Antithyroid Drug Treatment Remains the First Choice in Uncomplicated Graves’ Disease
A case of antithyroid drug-induced agranulocytosis from a second antithyroid drugs (ATD) administration in a relapsed Graves' disease patient who was tolerant to the first ATD treatment
The Effects of Long-Term Antithyroid Drug Treatment on Serum Reverse T3 in Patients with Graves' Disease
Can hyperthyroidism relapse after antithyroid drug treatment be predicted in children with Graves disease?
Which antithyroid drug regimen in paediatric Graves' disease?
Antithyroid drug treatment prior to radioiodine therapy for Graves’ disease: Yes or no?